Lord, Abbett & Co’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-54,000
| Closed | -$3.17M | – | 519 |
|
|
2024
Q1 | $3.17M | Buy |
+54,000
| New | +$3.17M | 0.01% | 507 |
|
|
2023
Q3 | – | Sell |
-1,068,143
| Closed | -$97.3M | – | 532 |
|
|
2023
Q2 | $97.3M | Buy |
1,068,143
+163,915
| +18% | +$14.9M | 0.34% | 87 |
|
|
2023
Q1 | $59.6M | Sell |
904,228
-228,395
| -20% | -$15.1M | 0.22% | 149 |
|
|
2022
Q4 | $58.6M | Buy |
1,132,623
+186,097
| +20% | +$9.62M | 0.21% | 133 |
|
|
2022
Q3 | $64.6M | Buy |
+946,526
| New | +$64.6M | 0.24% | 113 |
|